Simplex Trading, LLC Harvard Bioscience Inc Transaction History
Simplex Trading, LLC
- $3.28 Billion
- Q4 2024
A detailed history of Simplex Trading, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 6,679 shares of HBIO stock, worth $2,137. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,679
Previous 3,209
108.13%
Holding current value
$2,137
Previous $8,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding HBIO
# of Institutions
96Shares Held
32MCall Options Held
0Put Options Held
15K-
Amh Equity LTD3.39MShares$1.08 Million3.14% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$909,9680.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.76MShares$881,7920.35% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.68MShares$858,5600.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.16MShares$690,5130.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $13.3M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...